U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Natural Sprout Co LLC - 610151 - 09/02/2022
  1. Warning Letters

CLOSEOUT LETTER

Natural Sprout Co LLC MARCS-CMS 610151 —

Delivery Method:
VIA UPS
Product:
Dietary Supplements
Recipient:
Recipient Name
Stephen F. Aton
Recipient Title
Member
Natural Sprout Co LLC

1571 E. Cherokee Street
Springfield, MO 65804
United States

Issuing Office:
Division of Human and Animal Food Operations West II

United States

Dear Mr. Aton,

The Food and Drug Administration has completed an evaluation of Natural Sprout Co LLC corrective actions in response to our Warning Letter (CMS case #610151) on October 29, 2020. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
LaTonya M. Mitchell, Ph.D. 
District Director
FDA Kansas City District 
Program Division Director
Office Of Human and Animal Foods-West Division 2

Back to Top